S-Y Lin

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung cancer.

J. Roth, J. Lee, P. Gaudreau, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.

E. Jonasch, N. Rashid, L. Voorwerk, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer

R. Schiff, X. Cao, K. Li, 2016, Oncogene.

Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases

D. Boyd, M. Yamamoto, T Ishiguro, 2010, British Journal of Cancer.

Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

Shou‐Tung Chen, S. Kuo, Jan-Gowth Chang, 2004, International journal of molecular medicine.

Validation of cancer-type dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay.

E. Jonasch, N. Rashid, L. Voorwerk, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to: "Real-world prevalence across 159,872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab." by D. Fabrizio et al.

E. Jonasch, N. Rashid, L. Voorwerk, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.